Full-Time

Associate Director

Project Manager, Operational Data Strategy

Posted on 4/8/2025

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior

Mississauga, ON, Canada

Employees are required to work in the office 3 days a week.

Category
Project Management
Business & Strategy
Required Skills
Agile
Atlassian
JIRA
SCRUM
Requirements
  • Bachelor’s or Master’s degree in Project Management, Business Administration, or a related field.
  • Proven experience as a Project Manager in an Agile environment, managing complex projects and cross-functional teams within the domain of Operational Data Strategy.
  • Expertise in Atlassian tools, particularly Jira, with a deep understanding of Agile project management principles and best practices.
  • Advanced proficiency in Microsoft PowerPoint, with the ability to create compelling and informative presentations for various stakeholders.
  • Strong organizational and multitasking skills, with the ability to manage a portfolio of projects simultaneously.
Responsibilities
  • Lead and manage multiple projects within an Agile framework, ensuring timely delivery and alignment with the Operational Data Strategy and broader organizational goals.
  • Oversee and conduct scrum ceremonies, including sprint planning, daily stand-ups, sprint reviews, and retrospectives, ensuring effective collaboration and progress tracking.
  • Offer strategic updates and presentations to collaborators and senior leadership, using advanced PowerPoint abilities to communicate complex information clearly and effectively.
  • Apply Atlassian Jira for tracking project progress, managing backlogs, and facilitating transparent communication and collaboration within project teams.
  • Manage a portfolio of projects, prioritizing and allocating resources effectively to ensure successful delivery and alignment with operational data strategy and key strategic partners.
  • Effectively manage project budgets, secure agreement for prioritization, and negotiate for necessary resources, aligning financial management with project deliverables.
  • Foster a culture of continuous improvement and Agile standard methodologies within project teams, driving efficiency and innovation.
  • Effectively liaise with key strategic partners to align project deliverables with broader data strategy initiatives and ensure seamless collaboration.
  • Help the team focus on the current Sprint Goal by creating high-value increments that meet an agreed Definition of Done.
  • Ensure user stories/tasks are properly refined based on gathered requirements in close collaboration with the Senior Business Analyst, removing any possible impediments from the team.
  • Supervise the efficiency of the triage process and internal workflows, being the main contact for the Operational Data Support Specialist in case of critical issues.
  • Increase visibility and transparency by organizing internal (Ops Data Team/CDI) and external (engaging relevant AZ stakeholders) demonstrations of relevant increments or team achievements.
Desired Qualifications
  • Certification in Agile methodologies such as Certified ScrumMaster (CSM) or PMI Agile Certified Practitioner (PMI-ACP).
  • Experience in portfolio management and strategic project prioritization within the context of operational data strategy.

AstraZeneca focuses on discovering, developing, and selling prescription medicines, primarily in three areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are developed through extensive research and development, which includes rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery could enhance AstraZeneca's R&D efficiency.
  • Real-world evidence supports AstraZeneca's efforts in demonstrating drug efficacy and safety.
  • Personalized medicine aligns with AstraZeneca's focus on precision medicine.

What critics are saying

  • AstraZeneca faces a class-action lawsuit over alleged Soliris monopoly practices.
  • AI tools for breast cancer screening may face challenges due to minority underrepresentation.
  • Investment in Dunkirk may be at risk due to potential regulatory changes.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

INACTIVE